A day after it published its latest set of quarterly earnings, an analyst bumped his price target higher. He also maintained his equivalent of a buy recommendation. 10 stocks we like better than ...

Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...

Moolec Science Inc shares are surging on Friday after the company reported commercial-scale data from its U.S. GLASO ...

Exact Sciences is seeing consistent revenue growth in the low teens, driven by its flagship Cologuard test and expanding precision oncology offerings. Analysts are solidly bullish, with 15 analyst ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...

Achieve Life Sciences is a late-stage pharma company awaiting FDA approval for Cytisinicline, a novel smoking cessation ...